BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 88 filers reported holding BRIDGEBIO PHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $132,915,717 | +9.3% | 5,040,414 | -28.7% | 0.01% | +16.7% |
Q2 2023 | $121,592,992 | +42.6% | 7,069,360 | +37.5% | 0.01% | +20.0% |
Q1 2023 | $85,271,156 | -36.7% | 5,143,013 | -70.9% | 0.01% | +25.0% |
Q4 2022 | $134,796,932 | +70.7% | 17,689,886 | +122.7% | 0.00% | -20.0% |
Q3 2022 | $78,952,000 | -20.6% | 7,942,811 | -27.5% | 0.01% | -16.7% |
Q2 2022 | $99,490,000 | +6.5% | 10,957,063 | +19.0% | 0.01% | +20.0% |
Q1 2022 | $93,443,000 | +59.0% | 9,206,234 | +161.4% | 0.01% | +66.7% |
Q4 2021 | $58,755,000 | -59.4% | 3,522,463 | +14.2% | 0.00% | -62.5% |
Q3 2021 | $144,540,000 | -10.6% | 3,083,859 | +16.2% | 0.01% | -11.1% |
Q2 2021 | $161,757,000 | +11.0% | 2,653,496 | +12.2% | 0.01% | +12.5% |
Q1 2021 | $145,707,000 | -10.8% | 2,365,372 | +3.0% | 0.01% | -20.0% |
Q4 2020 | $163,306,000 | +84.9% | 2,296,523 | -2.5% | 0.01% | +66.7% |
Q3 2020 | $88,341,000 | -15.0% | 2,354,508 | -26.1% | 0.01% | -25.0% |
Q2 2020 | $103,906,000 | +109.1% | 3,186,321 | +85.9% | 0.01% | +100.0% |
Q1 2020 | $49,698,000 | +75.4% | 1,713,716 | +112.0% | 0.00% | +100.0% |
Q4 2019 | $28,329,000 | +275.2% | 808,243 | +129.9% | 0.00% | +100.0% |
Q3 2019 | $7,550,000 | – | 351,638 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 3,835,722 | $103,449,000 | 44.18% |
Kohlberg Kravis Roberts & Co. L.P. | 36,900,661 | $995,211,000 | 12.26% |
SC US (TTGP), LTD. | 2,544,738 | $68,632,000 | 4.69% |
Cormorant Asset Management, LP | 2,780,885 | $75,000,000 | 4.31% |
Perceptive Advisors | 6,706,268 | $180,868,000 | 4.15% |
VIKING GLOBAL INVESTORS LP | 26,620,991 | $717,968,000 | 3.22% |
Hillhouse Capital Management | 2,035,790 | $54,905,000 | 1.75% |
Alpine Group USVI, LLC | 20,000 | $539,000 | 1.70% |
HHLR ADVISORS, LTD. | 2,352,900 | $63,458,000 | 1.42% |
SCGE MANAGEMENT, L.P. | 588,235 | $15,865,000 | 0.79% |